Evidence map›Paper›PMID 42367347›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2026

Breathlessness Matters - Australian Cohort Study Evaluating the Impact of a Multidisciplinary, Home-Based Breathlessness Intervention Service Targeting Patients with Chronic Obstructive Pulmonary Disease (COPD).

Belinda Cochrane, Mohmedsaqib Zakirhusen Akhunji, Wei Xuan, Jonathan Shung-Yi Lee, Tracy A Smith, Sheree M Smith, Soo Wei Foo, Luisa Garcia, Teresa Anne Kemp

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Belinda CochraneDepartment of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.ORCID 0000-0001-8335-0353
Mohmedsaqib Zakirhusen AkhunjiDepartment of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.ORCID 0009-0002-4331-0458
Wei XuanSouth Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0001-7169-8299
Jonathan Shung-Yi LeeDepartment of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.ORCID 0009-0001-8700-6020
Tracy A SmithDepartment of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australia.ORCID 0000-0002-7729-3820
Sheree M SmithFaculty of Health and Medical Science, University of Adelaide, Adelaide, SA, Australia.ORCID 0000-0002-7469-1022
Soo Wei FooDepartment of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.ORCID 0009-0008-8763-4298
Luisa GarciaSchool of Nursing and Midwifery, Western Sydney University, Sydney, NSW, Australia.ORCID 0009-0003-6263-1625
Teresa Anne KempDepartment of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.ORCID 0009-0003-4550-2450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Chronic breathlessness causes reduced quality of life (QoL) and high healthcare costs. Accumulating evidence shows that multidisciplinary breathlessness services can ameliorate breathlessness which persists despite guideline-directed treatments. Current literature largely reflects trials of interventions in European settings applied to cancer-predominant populations, raising doubt about broad applicability. The research objective was to evaluate whether Macarthur Breathless Clinic (MBC), a bespoke health service intervention, could reduce the impact of chronic breathlessness for a cohort of Australians with COPD. Methods: The MBC intervention was tested in a prospective, single-arm cohort study, targeting recruitment of 92 patients. Eligible patients had chronic breathlessness impacting QoL and at least moderately severe COPD, defined by spirometry. Following detailed case review to ensure optimal medical therapy, an individualized program was developed and implemented by MBC's multidisciplinary team during a nine-week program. Questionnaires assessing breathlessness burden, mental health and QoL were administered at baseline, repeated on program completion and again at 12 months. Results: Eighty-nine eligible subjects were mean age 71 years, 65% female and 10% Aboriginal Australian with 18% reporting breathlessness at rest. Mean FEV1 was 37% predicted. Compared with baseline, the primary outcome, Chronic Respiratory Questionnaire - Mastery Subscale improved after program completion (0.5 at nine and 0.8 at 52 weeks, p<0.0001). Measures of confidence, COPD symptom burden and breathlessness also yielded durable positive results at 12 months. Conclusion: Clinically relevant gains seen after MBC were retained or even increased at 12 months and more reflected enhanced coping skills and confidence than reduced breathlessness intensity.

Indexed as

DyspneaHome Care ServicesLungPatient Care TeamPulmonary Disease, Chronic ObstructiveAgedAged, 80 and overAustraliaCost of IllnessFemaleForced Expiratory VolumeHumansMaleMental HealthMiddle AgedProspective Studiesdyspneanon-pharmacological strategiesquality of lifesymptom burden

Identifiers

PMID42367347
PMCPMC13308550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.